Intelligence Platform
Patents
Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8747843
Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as
granted patentUS 8741316
Highly porous, recognitive polymer systems
granted patentUS 8735440
Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds
granted patentUS 8735066
Tumor suppressor designated TS10Q23.3
granted patentUS 8734853
HDL particles for delivery of nucleic acids
granted patentUS 8728806
Methods and compositions related to Th-1 dendritic cells
granted patentUS 8728472
Antibodies that bind selectively to P25 and uses therefor
granted patentUS 8728499
Dendritic macroporous hydrogels prepared by crystal templating
granted patentUS 8728724
Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneratio
granted patentUS 8729047
Compositions for inhibiting redox-sensitive GTPases
granted patentUS 8729248
Sperm-specific cation channel, CATSPER2, and uses therefor
granted patentUS 8722716
Isoxazole treatments for diabetes
granted patentUS 8722871
VMP-like sequences of pathogenic borrelia species and strains
granted patentUS 8722628
Autophagy-inducing peptide
granted patentUS 8716258
Regulation of metabolism by miR-378
granted patentUS 8709342
Antimicrobial flush solutions
granted patentUS 8710017
Human and mouse targeting peptides identified by phage display
granted patentUS 8709430
Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospho
granted patentUS 8709391
Family of pain producing substances and methods to produce novel analgesic drugs
granted patentUS 8697034
Hyperpolarized 89-yttrium and methods relating thereto
granted patentUS 8685406
Compositions of and method of using heat shock protein peptides
granted patentUS 8686012
Stem cell differentiating agents and uses therefor
granted patentUS 8680094
1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment
granted patentUS 8668863
Dendritic macroporous hydrogels prepared by crystal templating
granted